# COVIDISC: Rapid Diagnostic Tests on Nasopharyngeal Swabs for the Detection of COVID-19

> **NCT04703140** · NA · TERMINATED · sponsor: **CMC Ambroise Paré** · enrollment: 192 (actual)

## Conditions studied

- COVID-19
- SARS-CoV-2

## Interventions

- **DIAGNOSTIC_TEST:** Rapid Diagnostic Test vs PCR

## Key facts

- **NCT ID:** NCT04703140
- **Lead sponsor:** CMC Ambroise Paré
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-01-27
- **Primary completion:** 2021-05-04
- **Final completion:** 2021-05-04
- **Target enrollment:** 192 (ACTUAL)
- **Why stopped:** Non-significant intemedial analysis
- **Last updated:** 2022-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04703140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04703140, "COVIDISC: Rapid Diagnostic Tests on Nasopharyngeal Swabs for the Detection of COVID-19". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04703140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*